Remixpoint
3825
Sanrio
8136
Nippon Telegraph & Telephone
9432
4
Kioxia Holdings
285A
5
Metaplanet
3350
JP Stock MarketDetailed Quotes
4564 OncoTherapy Science
- 29
- 00.00%
20min DelayMarket to Open Feb 17 15:30 JST
7.88BMarket Cap-4.79P/E (Static)
0High0Low0Volume0Open29Pre Close0.00Turnover6452wk High0.00%Turnover Ratio271.64MShares1552wk Low-4.81EPS TTM6.89BFloat Cap863Historical HighLossP/E (Static)237.68MShs Float15Historical Low-6.05EPS LYR0.00%Amplitude--Dividend TTM7.87P/B100Lot Size--Div YieldTTM
About OncoTherapy Science Company
OncoTherapy Science Inc focuses on cancer-related cells and genes and develops cancer therapy products which include low molecular drugs, antibody drugs, cancer peptide vaccine, and diagnostic medicine in Japan.
Company Profile
Symbol4564
Company NameOncoTherapy Science
Founded2001-04-06
MarketTSE Growth
Employees54
Fiscal Year Ends03-31
Address11th Floor, Kanagawa Science Park R&D 3-2-1 Sakado
Zip Code210-0005
Phone044-201-6429
Websitewww.oncotherapy.co.jp
Company Executives
- Name
- Position
- Salary
- Junichi Shimada
- President and Chief Executive Officer
- --
- Paku zai Ken
- Chief Scientific Officer and Director of Management Division
- --
- Toshio Kato
- Chairman of the Board
- --
- Yuichi Komine
- Independent Director
- --
- Yoshio Mitsuki
- Independent Director
- --